Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses

Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses

Human infections with highly pathogenic avian influenza H5N1 viruses persist as a major global health concern. Vaccination remains the primary protective strategy against H5N1 and other novel avian influenza virus infections. We investigated the use of <i>E. coli</i> type IIb heat labile...

Full description

Bibliographic Details
Main Authors: Neos Tang, Chun-Yi Lu, Shih-Che Sue, Ting-Hsuan Chen, Jia-Tsrong Jan, Ming-Hsi Huang, Chung-Hsiung Huang, Chung-Chu Chen, Bor-Luen Chiang, Li-Min Huang, Suh-Chin Wu
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Vaccines
Subjects:
intranasal immunization
mucosal adjuvant
LTIIb-B5
H5N1 vaccine
Online Access:https://www.mdpi.com/2076-393X/8/4/710

Internet

https://www.mdpi.com/2076-393X/8/4/710

Similar Items